If you have already registered, please check your email for the webinar link.
Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19
In this webinar, IsoPlexis product manager Victor Tek discusses how researchers used IsoPlexis’ low volume highly multiplexed bulk proteomics (CodePlex) to investigate the role of airway and plasma immune cells in the pathogenesis of severe COVID-19. Learn more about how IsoPlexis technology can accelerate your current or future research projects.
Available On Demand Now
Speaker
Victor Tek Product Manager IsoPlexis
Register Now for the On Demand Webinar
Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19
You must have Javascript and Cookies enabled to access this webcast.
For full details of how IsoPlexis will treat your information, please view their privacy policy
